Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Copanlisib

Copanlisib

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Copanlisib

12 trials tracked of Copanlisib: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 136 citations.

12Trials tracked
2Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 2 Phase 2 7 Phase 1 3
  1. Phase 3 Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL) Completed · 136 cited
  2. Phase 3 Phase III Copanlisib in Rituximab-refractory iNHL Completed
  3. Phase 2 A Study of Copanlisib and Ibrutinib in Mantle Cell Lymphoma Completed
  4. Phase 2 Phase II Copanlisib in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Completed
  5. Phase 2 Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma Completed
  6. Phase 2 Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer Completed
Show 6 more trials
  1. Phase 2 Copanlisib Hydrochloride and Nivolumab in Treating Patients With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell Lymphoma Completed
  2. Phase 2 Open-label, Uncontrolled Phase II Trial of Intravenous PI3K Inhibitor BAY80-6946 in Patients With Relapsed, Indolent or Aggressive Non-Hodgkin's Lymphomas Completed
  3. Phase 2 Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer Completed
  4. Phase 1 Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers Completed
  5. Phase 1 Effect of Copanlisib on Metformin Pharmacokinetics and Pharmacodynamics Completed
  6. Phase 1 Study of Copanlisib in Hepatic or Renal Impairment Completed

Showing the 12 most-cited and recently-updated of 12 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.